editorial

Visit the new smithsonian genome exhibit
We live in an age in which science and technology dominate every facet of our lives. From genomics to informatics, science matters. And yet the general public, our political leaders, and those who make important policy decisions all too frequently lack the most basic understanding of how our world works.
However, education is about much more than the imparting of facts and knowledge. Indeed, I would argue that the first job of an educator is to inspire and excite his or her audience-whether that audience is an elementary school classroom, medical students, or the public. Once a potential student has been captivated by a subject, the rest comes naturally as they actively seek further knowledge.
It is in part this aspect of educationthe need to inspire-that makes our nation's museums vital to an informed public. Now, the venerable Smithsonian National Museum of Natural History, in Washington, DC, is using its formidable power to inspire in the service of genomics education. On 14 June 2013, a new exhibit opened: "Genome: Unlocking Life's Code," cohosted by the National Human Genome Research Institute. Visitors learn about the power and beauty of genomics and explore, in a variety of interactive ways, multiple facets of the genome. They get a sense of the immense size of the genome, the analytical chalthe hereditary ataxias: a review see page 673
The hereditary ataxias often present with an array of overlapping symptoms that require molecular genetic testing to discriminate between them. All individuals with ataxia have problems with gross motor coordination due to defects in the nervous system that affect movement and balance. In addition, they may develop problems with eye movement, spasticity, neuropathy, and cognitive/behavioral difficulties. Establishing the specific molecular cause of hereditary ataxia for any given individual generally requires obtaining medical and family history, physical and neurologic examinations, and neuroimaging, in addition to molecular genetic testing. In this issue, Jayadev and Bird present the current understanding of these diverse disorders, including both the autosomal dominant and recessive forms, and review accepted steps for differential diagnosis. The authors review evaluation strategies, including non-DNA and DNA testing methods, as well as available prenatal testing for some forms of the disorder. Progress in identifying causative genes has enabled diagnosis of an estimated 50-60% of the dominant hereditary ataxias via a battery of genetic tests. Many laboratories first test for the genes associated with the more common ataxias (SCA1, SCA2, SCA3, SCA6, and SCA7), offering a second tier of tests only if the first group yields no positive diagnosis. Challenges and approaches to genetic counseling and disease management are also briefly covered. -Karyn Hede, News Editor research highlights ©American College of Medical Genetics and Genomics editorial lenges with which we are struggling, the potential for its application in medicine, and the light it sheds on who we are at the most fundamental level.
Generations of scientists have been inspired by their visits to museums where they first glimpsed the power and beauty of science. The sheer beauty of DNA and the human genome, coupled with the mastery of the Smithsonian's presentation, will inspire future generations about a subject important to society's future and dear to the heart of the readers of this journal.
"Genome: Unlocking Life's Code" will be open at the Smithsonian National Museum of Natural History through August 2014, after which it will travel throughout the United States. Plan to visit with your family! -James P. Evans, Editor-in-Chief 
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